Monitoring acute phase proteins in retrovirus infected cats undergoing feline interferon-ω therapy

Journal of Small Animal Practice

Volumn 55, Issue 1, 2014, Pages 39-45

  Leal, R O ^a   Gil, S ^a   Sepulveda N ^b,c   Mcgahie, D ^d   Duarte, A ^a   Niza, M M R E ^a   Tavares, L ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Center of Statistics Applications of Lisbon University CEAUL   (Portugal)

^d Virbac SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; FELIDAE;

C REACTIVE PROTEIN; INTERFERON; INTERFERON OMEGA 1; OROSOMUCOID; SERUM AMYLOID A;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA; FELINE LEUKEMIA VIRUS; FEMALE; LENTIVIRUS INFECTION; MALE; RETROVIRUS INFECTION; VIROLOGY;

ANIMALS; C-REACTIVE PROTEIN; CAT DISEASES; CATS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNODEFICIENCY VIRUS, FELINE; INTERFERON TYPE I; LENTIVIRUS INFECTIONS; LEUKEMIA VIRUS, FELINE; LEUKEMIA, FELINE; MALE; OROSOMUCOID; RETROVIRIDAE INFECTIONS; SERUM AMYLOID A PROTEIN;

EID: 84891662246     PISSN: 00224510     EISSN: 17485827     Source Type: Journal    
DOI: 10.1111/jsap.12160     Document Type: Article

References (34)

1. Barbai, V. H., Ujhelyi, E., Szlavik, J., etal. (2010) Changes in the levels of some acute-phase proteins in human immunodeficiency virus-1 infected patients, following interleukin-2 treatment. Clinical and Experimental Immunology 161, 134-141
2. Baumann, H. & Gauldie, J. (1994) The acute phase response. Immunology Today 15, 74-80
3. Ceciliani, F., Giordano, A. & Spagnolo, V. (2002) The systemic reaction during inflammation: the acute-phase proteins. Protein and Peptide Letters 9, 211-223
4. Ceron, J. J., Eckersall, P. D. & Martynez-Subiela, S. (2005) Acute phase proteins in dogs and cats: current knowledge and future perspectives. Veterinary Clinical Pathology 34, 85-99
5. Collado, V. M., Doménech, A., Gómez-Lucía, E., etal. (2006) Usos de interferón en la clínica de pequeños animales. Pequeños Animales 63, 68-75
6. de Mari, K., Maynard, L., Sanquer, A., etal. (2004) Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. Journal of Veterinary Internal Medicine 18, 477-482
7. Domenech, A., Miro, G., Collado, V. M., etal. (2011) Use of recombinant interferon omega in feline retrovirosis: from theory to practice. Veterinary Immunology and Immunopathology 143, 301-306
8. Duthie, S., Eckersall, P. D., Addie, D. D., etal. (1997) Value of alpha 1-acid glycoprotein in the diagnosis of feline infectious peritonitis. Veterinary Record 141, 299-303
9. Eckersall, P. D. & Bell, R. (2010) Acute phase proteins: biomarkers of infection and inflammation in veterinary medicine. Veterinary Journal 185, 23-27
10. Gleich, S. & Hartmann, K. (2009) Hematology and serum biochemistry of feline immunodeficiency virus-infected and feline leukemia virus-infected cats. Journal of Veterinary Internal Medicine 23, 552-558
11. Gil, S., Leal, R. O., Duarte, A., etal. (2013) Relevance of feline interferon omega for clinical improvement and reduction of concurrent viral excretion in retrovirus infected cats from a rescue shelter. Research in Veterinary Science 94, 753-763
12. Giordano, A., Spagnolo, V., Colombo, A., etal. (2004) Changes in some acute phase protein and immunoglobulin concentrations in cats affected by feline infectious peritonitis or exposed to feline coronavirus infection. Veterinary Journal 167, 38-44
13. Hartmann, K. (2011) Clinical aspects of feline immunodeficiency and feline leukemia virus infection. Veterinary Immunology and Immunopathology 143, 190-201
14. He, R., Shepard, L. W., Chen, J., etal. (2006) Serum amyloid A is an endogenous ligand that differentially induces IL-12 and IL-23. Journal of Immunology 177, 4072-4079
15. Hochepied, T., Berger, F. G., Baumann, H., etal. (2003) Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine and Growth Factor Reviews 14, 25-34
16. Hosie, M. J., Addie, D., Belak, S., etal. (2009) Feline immunodeficiency. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 11, 575-584
17. Jahoor, F., Gazzard, B., Phillips, G., etal. (1999) The acute-phase protein response to human immunodeficiency virus infection in human subjects. American Journal of Physiology 276, E1092-E1098
18. Kajikawa, T., Furuta, A., Onishi, T., etal. (1999) Changes in concentrations of serum amyloid A protein, alpha 1-acid glycoprotein, haptoglobin, and C-reactive protein in feline sera due to induced inflammation and surgery. Veterinary Immunology and Immunopathology 68, 91-98
19. Korman, R. M., Ceron, J. J., Knowles, T. G., etal. (2012) Acute phase response to Mycoplasma haemofelis and 'Candidatus Mycoplasma haemominutum' infection in FIV-infected and non-FIV-infected cats. Veterinary Journal 193, 433-438
20. Martínez-Subiela S, T. V. F., Parra Muñoz MD, Cerón JJM; (2001) Proteínas de fase aguda: conceptos básicos y principales aplicaciones clínicas en medicina veterinaria/Acute phase proteins: general concepts and main clinical applications in veterinary medicine. Anales de Veterinaria de Murcia 17, 97-113
21. Paltrinieri, S. (2008) The feline acute phase reaction. Veterinary Journal 177, 26-35
22. Paltrinieri, S., Giordano, A., Ceciliani, F., etal. (2004) Tissue distribution of a feline AGP related protein (fAGPrP) in cats with feline infectious peritonitis (FIP). Journal of Feline Medicine and Surgery 6, 99-105
23. Paltrinieri, S., Giordano, A., Tranquillo, V., etal. (2007a) Critical assessment of the diagnostic value of feline alpha1-acid glycoprotein for feline infectious peritonitis using the likelihood ratios approach. Journal of Veterinary Diagnostic Investigation 19, 266-272
24. Paltrinieri, S., Metzger, C., Battilani, M., etal. (2007b) Serum alpha1-acid glycoprotein (AGP) concentration in non-symptomatic cats with feline coronavirus (FCoV) infection. Journal of Feline Medicine and Surgery 9, 271-277
25. Petersen, H. H., Nielsen, J. P. & Heegaard, P. M. (2004) Application of acute phase protein measurements in veterinary clinical chemistry. Veterinary Research 35, 163-187
26. Sasaki, K., Ma, Z., Okazaki, K., etal. (2001) Characterization of monoclonal antibodies specific for feline serum amyloid (SAA) protein. Hybridoma 20, 103-108
27. Sasaki, K., Ma, Z., Khatlani, T. S., etal. (2003) Evaluation of feline serum amyloid A (SAA) as an inflammatory marker. Journal of Veterinary Medical Science 65, 545-548
28. Schultz, D. R. & Arnold, P. I. (1990) Properties of four acute phase proteins: C-reactive protein, serum amyloid a protein, α1-acid glycoprotein, and fibrinogen. Seminars in Arthritis and Rheumatism 20, 129-147
29. Selting, K. A., Ogilvie, G. K., Lana, S. E., etal. (2000) Serum alhpa 1-acid glycoprotein concentrations in healthy and tumor-bearing cats. Journal of Veterinary Internal Medicine 14, 503-506
30. Tamamoto, T., Ohno, K., Ohmi, A., etal. (2008) Verification of measurement of the feline serum amyloid A (SAA) concentration by human SAA turbidimetric immunoassay and its clinical application. Journal of Veterinary Medical Science 70, 1247-1252
31. Tamamoto, T., Ohno, K., Ohmi, A., etal. (2009) Time-course monitoring of serum amyloid A in a cat with pancreatitis. Veterinary Clinical Pathology 38, 83-86
32. Treitinger, A., Spada, C., da Silva, L. M., etal. (2001) Lipid and acute-phase protein alterations in HIV-1 infected patients in the early stages of infection: correlation with CD4+ lymphocytes. Brazilian Journal of Infectious Disease 5, 192-199
33. Uhlar, C. M. & Whitehead, A. S. (1999) Serum amyloid A, the major vertebrate acute-phase reactant. European Journal of Biochemistry 265, 501-523
34. Wasunna, K. M., Raynes, J. G., Were, J. B., etal. (1995) Acute phase protein concentrations predict parasite clearance rate during therapy for visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine & Hygiene 89, 678-681